Gene: S1PR1
Official Full Name: sphingosine-1-phosphate receptor 1provided by HGNC
Gene Summary: The protein encoded by this gene is structurally similar to G protein-coupled receptors and is highly expressed in endothelial cells. It binds the ligand sphingosine-1-phosphate with high affinity and high specificity, and suggested to be involved in the processes that regulate the differentiation of endothelial cells. Activation of this receptor induces cell-cell adhesion. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2016]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO09647 | S1PR1 Knockout cell line (HeLa) | Human | S1PR1 | 1:3~1:6 | Negative | Online Inquiry |
KO09648 | S1PR1 Knockout cell line (HEK293) | Human | S1PR1 | 1:3~1:6 | Negative | Online Inquiry |
S1PR1 Gene Knockout Cell Lines are specialized cellular models engineered to lack the functional S1PR1 gene, which encodes the sphingosine-1-phosphate receptor 1. This receptor is critically involved in various physiological processes, including immune cell trafficking, vascular integrity, and neuronal development. By creating knockout models, researchers can investigate the role of S1PR1 in health and disease more effectively, allowing for a deeper understanding of its contributions to cellular signaling pathways and overall biological functions.
The primary function of S1PR1 is to mediate responses to sphingosine-1-phosphate, a bioactive lipid involved in cell proliferation, migration, and survival. The absence of S1PR1 in these knockout cell lines allows researchers to dissect the downstream effects of its signaling disruption, including altered cytoskeletal dynamics and immune responses. The mechanism by which S1PR1 operates showcases its importance in not only normal physiology but also in various pathological contexts such as cancer, cardiovascular diseases, and neurodegenerative disorders.
These cell lines hold significant scientific importance as they provide a valuable platform for exploring therapeutic targets and validating drug candidates. In clinical research, S1PR1's involvement in immune modulation signifies its potential as a target for therapeutic intervention in autoimmune disorders. The unique ability of these knockout models to mimic disease states can facilitate the discovery of novel treatment strategies.
One of the key advantages of S1PR1 Gene Knockout Cell Lines is their ability to offer unmatched specificity in experimentation, reducing background noise often encountered with other model systems. Compared to traditional pharmacological inhibitors that may have off-target effects, these genetically modified lines permit clearer insights into S1PR1-related mechanisms, thereby ensuring more reliable and reproducible outcomes.
For researchers and clinicians focused on unraveling the complexities of cellular signaling pathways or developing targeted therapies, the S1PR1 Gene Knockout Cell Lines represent an invaluable tool. They empower users to make precise investigations into the intricacies of sphingosine-1-phosphate signaling, providing a deeper understanding essential for advancing medical research.
As a leader in biological product development, our company is committed to delivering high-quality, innovative cellular models that enhance research capabilities and drive scientific discovery.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.